BioPharma Pharma Research
The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...
June 24, 2021 | News
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using World's Fastest Supercomputer with Researchers of Research Center for Advanced Science...
June 22, 2021 | News
Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies...
June 21, 2021 | News
In contrast, non-viral delivery systems are expected to have a better safety profile and with simplified manufacturing, offer the potential for a templated...
June 18, 2021 | News | By Nargisse El Hajjami, Dr1, Manuel Brantner, Mag.2, Anissa Boumlic, Dr3, Shiksha Mantri, 4, Bahar Cebi, 5 1Associate Director Cell and Gene Therapy Segment EMEA, 2Associate Director Vaccine and Plasma Segment EMEA, 3Head of Global Vaccine & Plasma Segments
Therapies developed on the Illuminox platform involve administering a targeting moiety conjugated with one or more dyes, which is illuminated by light at a...
June 18, 2021 | News
Data Presented at the Global Hepatitis Summit Show that Virally Suppressed Patients from Taiwan with Renal or Hepatic Impairment had High Rates of Vi...
June 18, 2021 | News
Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech co...
June 17, 2021 | News
New findings from Cleveland Clinic researchers show for the first time that the gut microbiome impacts stroke severity and functional impairment ...
June 17, 2021 | News
The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...
June 16, 2021 | News
Sermo, the world’s leading HCP insights company and the first social media platform for physicians, today announced its acquisition of Australia-base...
June 15, 2021 | News
ATTRACT-3 trial is a randomized, double-blind, placebo-controlled, multinational, phase 3 trial that will include 600 adult patients hospitalized with COVI...
June 14, 2021 | News
By combining Ritter's liquid dispensing platform for clinical diagnostic testing and life sciences research with Avantor's offerings for critical lab autom...
June 12, 2021 | News
Explora BioLabs, a national provider of preclinical vivarium space, vivarium management services, and contract research services, today announced it ...
June 11, 2021 | News
$40 million upfront including $25 million cash and $15 million in equity in Nuance Biotech (parent company) Up to $179 million in potential clinical, regul...
June 11, 2021 | News
Most Read
Bio Jobs
News